This federal contract award was issued by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices, for the delivery of the ELUVIA Drug Eluting Stent. The $5,122.84 fixed-price with economic price adjustment contract has a completion date of December 20, 2024. Boston Scientific, doing business as Boston Scientific, specializes in developing innovative, minimally invasive medical technologies for use in various clinical areas, including cardiovascular, rhythm management, and peripheral interventions. This contract award supports the Defense Health Agency's (DHA) and Department of Veterans Affairs' (VA) healthcare initiatives by providing advanced medical devices to serve military and veteran populations. Boston Scientific has received multiple federal contract awards and has participated as a subrecipient in grant-funded research and development efforts related to bioelectronic medicine. The contract does not have a set-aside designation.
Generated 3/14/25, 9:44 AM